Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study

Autor: Moran, T, Taus, A, Arriola, E, Aguado, C, Domine, M, Rueda, AG, Calles, A, Cedres, S, Vinolas, N, Isla, D, Palmero, R, Sereno, M, Diaz, V, Juan, O, Marse, R, Martorell, PM, Torres, JMS

Publikováno v: Clinical Lung Cancer
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
CLINICAL LUNG CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

We report the results of the molecular and clinical characterization and the efficacy of afatinib in a cohort of patients with advanced nonesmall-cell lung cancer (NSCLC) patients harboring uncommon epidermal growth factor receptor (EGFR) mutations i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a4086364bee3a3d3268e0a246c459025
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3534

NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)

Autor: Guirado, M, Majem, M, Sureda, BM, Bataller, RD, Granados, ALO, Casado, MDI, Gomez, MD, Fabregat, RM, Sala, MA, Lario, AP, Bueno, MTM, Estevez, SV, Sarto, JC, Gonzalez-Larriba, JL, Torres, JMS, Vicente, D, Bernado, NF, Fernandez-Fornos, L, Varcarcel, F, Provencio, M

Publikováno v: Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::f08d32ffae5a637689d38878b482d03c
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4270

Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.

Autor: Aparicio I; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain; Facultad de Medicina, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Madrid, Spain., Iranzo P; Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Reyes R; Medical Oncology Department, Thoracic Oncology Unit, Hospital Clinic, IDIBAPS, Barcelona, Spain., Bote H; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain;-H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octubre (i+12), Madrid, Spain., Saigi M; Medical Oncology Department, Hospital Germans Trías i Pujol, Institut Català d'Oncologia-ICO, Badalona, Barcelona, Spain., Bringas M; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Bosch-Barrera J; Medical Oncology, Catalan Institute of Oncology, Hospital Universitari Dr. Josep Trueta, 17007 Girona, Spain. Precision Oncology Group (OncoGIR-Pro), Institut d'Investigació Biomèdica de Girona (IDIBGI), 17190, Salt, Spain., Corral J; Clínica Universidad de Navarra, Department of Oncology, Pamplona, Spain., Aparisi F; Medical Oncology Department, Hospital General Universitario de Valencia, Department of Medicine, Universitat de València, TRIAL Mixed Unit, Centro Investigación Príncipe Felipe-Fundación Investigación Hospital General Universitario de Valencia. CIBERONC, Valencia, Spain., Ruffinelli JC; Medical Oncology Department, Centre Sanitari i Universitari de Bellvitge, Institut Català d'Oncologia (-ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Jiménez B; Hospital HM Universitario Sanchinarro-CIOCC, Madrid, Spain., Lage Y; Medical Oncology Department; Ramón y Cajal University Hospital, Madrid, Spain., López-Castro R; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Majem M; Department of Medical Oncology; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Vázquez S; Medical Oncology, Hospital Universitario Lucus Augusti, Lugo, Spain., Artal Á; Medical Oncology Service, Hospital Universitario Miguel Servet, Zaragoza, Spain., Rodríguez-Pérez Á; Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Lázaro-Quintela M; Medical Oncology Department, Hospital Universitario Alvaro Cunqueiro, Vigo, Spain., Torres JMS; Department of Medical Oncology, La Princesa University Hospital, Madrid, Spain., Reguart N; Medical Oncology Department, Thoracic Oncology Unit, Hospital Clinic, IDIBAPS, Barcelona, Spain., Cucurull M; Medical Oncology Department, Hospital Germans Trías i Pujol, Institut Català d'Oncologia-ICO, Badalona, Barcelona, Spain., Gil-Bazo I; Clínica Universidad de Navarra, Department of Oncology, Pamplona, Spain; Instituto Valenciano de Oncología, Department of Oncology, Valencia, Spain., Camps C; Medical Oncology Department, Hospital General Universitario de Valencia, Department of Medicine, Universitat de València, TRIAL Mixed Unit, Centro Investigación Príncipe Felipe-Fundación Investigación Hospital General Universitario de Valencia. CIBERONC, Valencia, Spain., Nadal E; Medical Oncology Department, Centre Sanitari i Universitari de Bellvitge, Institut Català d'Oncologia (-ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Del Barrio A; Hospital HM Universitario Sanchinarro-CIOCC, Madrid, Spain., Garrido P; Medical Oncology Department; Ramón y Cajal University Hospital, Madrid, Spain., Dómine M; Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Álvarez R; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Muñoz AJ; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Calles A; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. Electronic address: antonio.calles@salud.madrid.org.

Publikováno v: Thrombosis research [Thromb Res] 2023 Dec; Vol. 232, pp. 133-137. Date of Electronic Publication: 2023 Nov 12.